The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 12, 2006, Pages 1393-1398

  Kim, S J ^a   Suk, M H ^b   Choi, H M A ^c   Kimm, K C ^d   Jung, K H ^a   Lee, S Y ^e,f   Kim, Je Hyeong ^a   Shin, C ^a   Shim, J J ^e   In, K H ^f   Kang, K H ^e   Yoo, S H ^f  

^a Korea University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Columbia University ^*  (United States)

^d Korea Centers for Disease Control and Prevention   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Korea University College of Medicine   (South Korea)

Author keywords

COPD; Epidemiology; GOLD; Korea; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; INCOME; LIFESTYLE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE; SEX RATIO; SPIROMETRY;

ADULT; AGED; BRONCHODILATOR AGENTS; BRONCHOSPIROMETRY; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33845523115     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pauwels R A, Buist A S, Ma P, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001; 46: 798-825.
2. Murray C J, Lopez A D. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996; 274: 740-743.
3. Hurd S S. International efforts directed at attacking the problem of COPD. Chest 2000; 117 (Suppl): S336-S338.
4. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 (Suppl): S77-S121.
5. Siafakas N M, Vermeire P, Pride N B, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8: 1398-1420.
6. McLean K. The pathogenesis of pulmonary emphysema. Am J Med 1958; 25: 62-74.
7. Peinado V I, Barbera J A, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1605-1611.
8. Repine J E, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997; 156: 341-357.
9. Saetta M, Di Stefano A, Maestrelli P, et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147: 301-306.
10. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 822-826.
11. Wright J L, Lawson L, Pare P D, et al. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise. Am Rev Respir Dis 1983; 128: 702-707.
12. 1. Eur Respir J 2004; 23: 497-498.
13. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59: 120-125.
14. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004; 9: 458-465.
15. Kim D S, Kim Y S, Jung K S, et al. Prevalence of chronic obstructive pulmonary disease in Korea: A population-based spirometry survey. Am J Respir Crit Care Med 2005; 172: 842-847.
16. Vestbo J, Lange P. Can GOLD Stage O provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166: 329-332.
17. Johannessen A, Omenaas E R, Bakke P S, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-847.
18. Psaty B M, Cheadle A, Koepsell T D, et al. Race- and ethnicity-specific characteristics of participants lost to follow-up in a telephone cohort. Am J Epidemiol 1994; 140: 161-171.
19. de Marco R, Zanolin M E, Accordini S, et al. A new questionnaire for the repeat of the first stage of the European Community Respiratory Health Survey: a pilot study. Eur Respir J 1999; 14: 1044-1048.
20. Burney P G, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
21. American Thoracic Society. Standardization of spirometry. 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
22. Morris J F. Spirometry in the evaluation of pulmonary function. West J Med 1976; 125: 110-118.
23. Global Institute for Chronic Obstructive Lung Disease. Workshop report: global strategy for diagnosis, management, and prevention of COPD. 2005 update. Geneva, Switzerland: GOLD, 2005. http://www.goldcopd.org Accessed August 2006.
24. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs. American Thoracic Society definition. Chest 2000; 117 (Suppl): S339-S345.
25. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144: 1202-1218.
26. Lange P, Groth S, Nyboe J, et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J Intern Med 1989; 226: 25-32.
27. Etter J F, Perneger T V. Analysis of non-response bias in a mailed health survey. J Clin Epidemiol 1997; 50: 1123-1128.
28. Snider G L, Doctor L, Demas T A, Shaw A R. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971; 103: 625-640.
29. Willcox P A, Ferguson A D. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med 1989; 83: 195-198.
30. Menezes A M, Perez-Padilla R, Jardim J R, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.